Genetic risk score for predicting pancreatic cancer
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study uses a genetic score to better predict a person's risk of developing pancreatic cancer. It includes both people with and without the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be able and willing to give your informed consent.
- You either have pancreatic ductal adenocarcinoma (a common type of pancreatic cancer) or you do not have it (as a comparison group).
- Your medical and/or biological data needed for the study must be available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers genetic testing to people at higher risk for pancreatic cancer, especially those with a family history or certain genetic changes. It aims to help you understand your risk and possibly catch cancer early.
This study is a registry for people at high risk for pancreatic cancer. Researchers will collect information over time to learn more about how to detect and prevent the disease.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
This study builds a database of people at higher risk for pancreatic cancer (or certain early warning findings) to help find better ways to detect the disease early. You may be asked to complete health questionnaires and possibly donate a blood/saliva/swab sample.
Hear when a new Pancreatic Ductal Adenocarcinoma (mPDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.